2025-10-03 - Analysis Report
Okay, here's an analysis of Rocket Lab USA Inc. (RKLB), incorporating the data you've provided.  The report will be in English, start with key figures, and include a brief analysis after each section.

---

**Report: Rocket Lab USA Inc. (RKLB) Analysis**

Rocket Lab USA Inc. is a space company that provides launch services and space systems.

**1. Performance vs. S&P 500 (VOO)**

*   **RKLB Cumulative Return:** 263.61%
*   **VOO Cumulative Return:** 46.99%
*   **Spread:**
    *   Max: 301.6
    *   Min: -44.6
    *   Current: 216.6
    *   Relative Spread: 75.4

**Analysis:** RKLB has significantly outperformed the S&P 500 (VOO) over the tracked period. However, the relative spread of 75.4 indicates that while RKLB's outperformance is substantial, it's not at the extreme upper end of its historical range relative to the index.

**Alpha, Beta Analysis**

| Year       | CAGR    | MDD     | Alpha  | Beta   | Cap(B) |
| :----------- | :------ | :------ | :----- | :----- | :------- |
| 2020-2022  | -38.0%  | 82.7%   | -18.0% | 0.1    | 1.8      |
| 2021-2023  | 3.0%   | 82.7%   | 2.0%   | 0.0    | 2.7      |
| 2022-2024  | 210.0% | 82.7%   | 189.0% | 0.0    | 12.3     |
| 2023-2025  | 284.0% | 79.6%   | 222.0% | -0.0   | 22.6     |

**Analysis:**
*   **CAGR:**  The Compound Annual Growth Rate shows a significant turnaround in recent years.
*   **MDD:** The Maximum Drawdown is consistently high, indicating substantial volatility.
*   **Alpha:** Alpha is very high in recent years, signifying significant outperformance compared to its benchmark.
*   **Beta:** Beta is very low, indicating RKLB's returns are relatively independent of the market (S&P 500).
*   **Cap:** Market capitalization has grown substantially over the periods, showing company growth.

**2. Recent Price Action**

*   **Current Price:** 46.82
*   **Last Market Close:** Price: 52.47, Previous Close: 47.97, Change: 9.38
*   **5-Day Moving Average:** 47.74
*   **20-Day Moving Average:** 47.69
*   **60-Day Moving Average:** 45.72

**Analysis:** The stock price experienced a significant jump in the last market close. The 5-day and 20-day moving averages are close, suggesting a potential consolidation phase, while the 60-day moving average is lower, implying that the recent surge is a relatively new development.

**3. Indicators & Expected Return**

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 49.57
*   **PPO:** -0.91
*   **Hybrid Signal:** Cash 0%, Buy 100% (21 shares)
*   **Recent (20-Day) Relative Spread Change:** -6.5 (Down)
*   **Expected Return:** 3.8% (vs. S&P 500)

**Analysis:** The MRI suggests a high investment recommendation based on the model. The RSI is near neutral (50), not indicating overbought or oversold conditions. PPO is slightly negative, indicating a downtrend. The Hybrid Signal suggests buying. The recent decrease in relative spread indicates underperformance compared to S&P 500 recently. The expected return is positive, which suggests potential long-term outperformance. The significant jump in price (change of 9.38) suggests news or event driven momentum.

**4. Recent News & Significant Events**

*   **[2025-10-02]** Why Is Rocket Lab (RKLB) Stock Soaring Today (StockStory)
*   **[2025-09-29]** Rocket Lab and Synspective Strike Another 10-Launch Deal, Boosting Contracted Missions to 21 Electron Launches (GlobeNewswire)
*   **[2025-09-29]** Jeff Bezos' Blue Origin To Ramp Up Launches, Rivals Score These Wins (Investor's Business Daily)
*   **[2025-09-25]** Insider Alert: Rocket Lab CFO Dumps $42 Million in Stock (GuruFocus.com)
*   **[2025-09-25]** AI, robotics, & space market boom: How to profit (Yahoo Finance Video)
*   **[2025-09-25]** Rocket Lab (RKLB): Buy, Sell, or Hold Post Q2 Earnings? (StockStory)

**Analysis:** The news is mixed. The recent surge is likely due to the Synspective deal and overall positive sentiment towards the space market. However, the CFO's stock sale is a potential concern. Consider the Q2 earnings analysis to get more insights.

**4-2. Analyst Opinions**

*   **Consensus:** Buy (~1.85)
*   **Opinions:** 11
*   **Target Price:** Avg: 46.73 / High: 60.00 / Low: 20.00
*   **Recent Rating Changes:** Not provided.

**Analysis:**  The analyst consensus is a "Buy." The average target price is close to the current price before the last market jump, with a wide range between the high and low targets, reflecting differing opinions on the stock's potential.

**5. Recent Earnings Analysis**

| Date       | EPS   | Revenue    |
| :---------- | :---- | :--------- |
| 2025-08-07 | -0.13 | 0.14 B$   |
| 2025-05-08 | -0.12 | 0.12 B$   |
| 2024-11-12 | -0.10 | 0.10 B$   |
| 2024-08-08 | -0.08 | 0.11 B$   |
| 2025-08-07 | -0.08 | 0.11 B$   |

**Analysis:** The company is not yet profitable, with negative EPS figures.  Revenue has been generally increasing, which is a positive sign.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
| :--------- | :------- | :-------------- |
| 2025-06-30 | $0.14B   | 32.10%        |
| 2025-03-31 | $0.12B   | 28.76%        |
| 2024-12-31 | $0.13B   | 27.81%        |
| 2024-09-30 | $0.10B   | 26.71%        |
| 2024-06-30 | $0.11B   | 25.56%        |

**Capital and Profitability:**

| Quarter    | Equity  | ROE        |
| :--------- | :------- | :---------- |
| 2025-06-30 | $0.69B   | -9.65%    |
| 2025-03-31 | $0.43B   | -14.05%   |
| 2024-12-31 | $0.38B   | -13.69%   |
| 2024-09-30 | $0.42B   | -12.37%   |
| 2024-06-30 | $0.46B   | -9.15%    |

**Analysis:** Revenue is growing, and profit margins are increasing, which is a positive trend. However, Return on Equity (ROE) is negative, reflecting the company's current lack of profitability.  Equity has seen some fluctuation.

**7. Overall Summary**

Rocket Lab (RKLB) is a high-growth company in the space sector. It has significantly outperformed the S&P 500, but with substantial volatility. Recent news indicates positive momentum from new deals, but also potential concern from insider selling. Analyst consensus is "Buy," and revenue and profit margins are improving. However, the company is not yet profitable, and negative ROE remains a concern. The MRI indicator suggesting investment while incorporating the recent price movement and underperformance of the stock.
